Evidence map›Paper›PMID 40036318›Full record

ReviewJournal of breast imaging2025

Mathematical Modeling to Address Questions in Breast Cancer Screening: An Overview of the Breast Cancer Models of the Cancer Intervention and Surveillance Modeling Network.

Oguzhan Alagoz, Jennifer L Caswell-Jin, Harry J de Koning, Hui Huang, Xuelin Huang, Sandra J Lee, Yisheng Li, Sylvia K Plevritis, Swarnavo Sarkar, Clyde B Schechter and 5 more

Abstract readReview
In one paragraph

Review in Journal of breast imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Oguzhan AlagozDepartment of Industrial and Systems Engineering, University of Wisconsin-Madison, Madison, WI, USA.ORCID 0000-0002-5133-1382
Jennifer L Caswell-JinDepartment of Medicine, Stanford University School of Medicine, Stanford, CA, USA.ORCID 0000-0002-5711-8355
Harry J de KoningDepartment of Public Health, Erasmus Medical Center, Rotterdam, The Netherlands.ORCID 0000-0003-4682-3646
Hui HuangDepartment of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID 0000-0002-5372-3160
Xuelin HuangDepartment of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID 0000-0003-1192-9336
Sandra J LeeDepartment of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.
Yisheng LiDepartment of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID 0000-0001-9847-8544
Sylvia K PlevritisDepartment of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA, USA.
Swarnavo SarkarGeorgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.ORCID 0000-0002-1830-3099
Clyde B SchechterDepartment of Family & Social Medicine, Albert Einstein College of Medicine, The Bronx, NY, USA.
Natasha K StoutDivision of Cancer Control and Population Sciences, National Cancer Institute, National Institute of Health, Bethesda, MD, USA.
Amy Trentham-DietzDepartment of Population Health Sciences, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA.ORCID 0000-0002-5971-4660
Nicolien van RavesteynDepartment of Public Health, Erasmus Medical Center, Rotterdam, The Netherlands.
Kathryn P LowryDepartment of Radiology, University of Washington School of Medicine, Fred Hutchinson Cancer Center, Seattle, WA, USA.ORCID 0000-0002-0840-7855
from the CISNET Breast  Working Group

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI Christian Capitini · 1985 to 2026
$142.6M
Comparative Modeling of Precision Breast Cancer Control Across the Translational Continuum - SupplementU01CA253911 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI ALAGOZ, OGUZHAN, DE KONING, HARRY J · 2020 to 2025
$10.6M
American Cancer Society 21-078-01-CPSHNCI NIH HHS P30 CA014520NCI NIH HHS U01 CA253911NIH HHS U01CA253911, P30CA014520
6 · The paper itself

Abstract

The National Cancer Institute-funded Cancer Intervention and Surveillance Modeling Network (CISNET) breast cancer mathematical models have been increasingly utilized by policymakers to address breast cancer screening policy decisions and influence clinical practice. These well-established and validated models have a successful track record of use in collaborations spanning over 2 decades. While mathematical modeling is a valuable approach to translate short-term screening performance data into long-term breast cancer outcomes, it is inherently complex and requires numerous inputs to approximate the impacts of breast cancer screening. This review article describes the 6 independently developed CISNET breast cancer models, with a particular focus on how they represent breast cancer screening and estimate the contribution of screening to breast cancer mortality reduction and improvements in life expectancy. We also describe differences in structures and assumptions across the models and how variation in model results can highlight areas of uncertainty. Finally, we offer insight into how the results generated by the models can be used to aid decision-making regarding breast cancer screening policy.

Indexed as

Breast NeoplasmsEarly Detection of CancerModels, TheoreticalFemaleHumansMammographyUnited Statesbreast cancer screeningmammographymammography screeningsimulation modeling

Identifiers

PMID40036318
PMCPMC11920616

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.